In July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act was signed into law. Included in this act is Section 1502 (the "Conflict Minerals Provision") which requires public companies to disclose in the body of its annual report any purchase or use in their products of conflict minerals - tin, tungsten, tantalum and gold that originate from the Democratic Republic of the Congo ("DRC") and adjoining countries.
ICUMED will not knowingly participate in activities or providing funds to vendors in its supply-chain that directly or indirectly finance or benefit organizations, non-government military groups or unlawful military factions that exploit and abuse human rights.
ICUMED and all of its employees are committed to conducting its business in a lawful and ethical manner and expect its suppliers to conduct themselves in likewise manner. ICUMED has an Ethical Code of Conduct and Legal Compliance Policy which applies to all employees and board members of the company (collectively, "Employees"). This code of conduct requires Employees to comply with all applicable federal, state and local laws and regulations. We expect our suppliers to conform to our Code of Conduct.
ICUMED will be compliant with this act and all other regulations relating to the sourcing of raw materials containing conflict minerals and we have implemented internal controls and procedures in support of this. We have obtained written statements from our suppliers affirming that our supply chain is free of any conflict minerals sourced from the DRC or adjoining countries. Additionally, we require our suppliers to be able to provide, upon request, documentation that shows the due diligence steps they performed to support their affirmation.
ICUMED is committed and will continue to take the necessary steps to ensure that products we receive from our suppliers are responsibly sourced and fully comply with Dodd-Frank Wall Street Reform and Consumer Protection Act.
An unknown error occurred.
Your submission has been received!